DOC

Six S&P 500 'safer' high-yield dividend stocks—Regions Financial, Ford, AT&T, Pfizer, Verizon, VICI Properties—currently offer attractive buy signals based on free cash flow yields. Analyst projections for the top ten S&P 500 dividend dogs indicate potential net gains of 14.54% to 40.07% by November 2027, with an average estimated gain of 27.42%. Dividend dog strategy favors stocks where annual dividends from $1,000 invested exceed single-share prices and free cash flow yields surpass dividend yields.

Healthpeak Properties is a 5% portfolio position, driven by a bullish multi-year Life Science turnaround thesis and acquisition-led growth potential. Q3 2026 guidance was revised upward, with the FFO midpoint now $1.77 and the FFO payout ratio improving to 69%, reflecting operational resilience. Lab segment occupancy increased 130 bps sequentially, with year-over-year same-store NOI trending toward positive territory, supporting future AFFO growth.

Healthpeak Properties is reiterated as a Buy, driven by resilient earnings, another guidance boost, and a compelling valuation offering a good margin of safety. DOC's Lab segment shows signs of stabilization and potential rebound, supported by strong occupancy gains and positive leasing momentum. Outpatient Medical and Senior Housing segments deliver robust growth, with Senior Housing posting a 25.9% NOI increase amid very strong performance from Janus Living.

Healthpeak Properties NYSE: DOC raised its full-year earnings outlook for the third time in 2026 after reporting what President and Chief Executive Officer Scott Brinker described as a strong operational quarter across outpatient medical, life science and senior housing.

DOC's Q3 2026 FFOA and revenues beat estimates, driven by solid outpatient leasing and senior housing growth, prompting an upgraded full-year FFOA outlook.

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak"), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the quarter ended September 30, 2026. THIRD QUARTER 2026 FINANCIAL PERFORMANCE AND RECENT HIGHLIGHTS Net income of $0.02 per share and FFO as Adjusted of $0.44 per share Outpatient Medical new and renewal lease executions totaled 846,000 square feet, bringing year-to-date Outpatient Medical lea.

DOC is set to report Q3 earnings, with revenue growth expected to offset FFOA declines amid strong senior housing demand and lab market challenges.

October's top ten monthly-pay dividend equities offer forecasted net gains from 28.06% to 89.66% by 2027, with an average gain of 50.94%. Banco BBVA Argentina (BBAR) and Banco Macro (BMA) lead the MoPay group, with analyst targets implying the highest total returns and significant price upsides. Yield-based MoPay stock selection proved 70–80% accurate versus analyst upside forecasts, favoring financial and real estate sectors for both yield and price appreciation.

Rate Shock: REITs enter earnings season on their back foot amid a renewed surge in long-term rates, facing a materially different cost-of-capital and financing environment than just three months ago. The rate surge is again stressing highly leveraged borrowers, particularly across private markets. Public REITs are better positioned, but remain exposed through refinancing, tenant credit, and equity valuations. Higher rates have brought an important silver lining: years of expensive capital are finally curbing construction, with shrinking pipelines beginning to support occupancy, rents, and landlord pricing power.

Healthpeak Properties offers a compelling 6.5% monthly dividend yield, supported by a BBB+ balance sheet and well-covered payout ratio. DOC trades at 10.65x forward FFO, well below its historical P/FFO of 14.0, presenting an attractive entry point after a recent dip. Outpatient medical and senior housing segments deliver steady results, while life science occupancy shows early signs of recovery amid sector headwinds.